We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 3,653 results
  1. Virtual Screening Process: A Guide in Modern Drug Designing

    Due to its capacity to drastically cut the cost and time necessary for experimental screening of compounds, virtual screening (VS) has grown to be a...
    Umesh Panwar, Aarthy Murali, ... Sanjeev Kumar Singh in Computational Drug Discovery and Design
    Protocol 2024
  2. Understanding the Role of Scavenger Receptor A1 in Nanoparticle Uptake by Murine Macrophages

    Nanoparticles can be cleared from the circulation and taken up by tissue-resident macrophages. This property can be beneficial when drug or antigen...
    Edward Cedrone, Martin Schuster, ... Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  3. Computer-Aided Drug Discovery and Design: Recent Advances and Future Prospects

    Computer-aided drug discovery and design involve the use of information technologies to identify and develop, on a rational ground, chemical...
    Protocol 2024
  4. Immunophenoty**, Part I: Instrument Calibration and Reagent Qualification for Immunophenoty** Analysis of Human Peripheral Blood Mononuclear Cell Cultures

    Nanoparticles are increasingly used in biomedical applications to influence the way the immune system reacts to tumors and infectious disease-causing...
    Hannah S. Newton, Jenny Zhang, Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  5. Measuring Size and Number Concentration of Metallic Nanoparticles Using spICP-MS

    This protocol describes how to measure the size and concentration of individual metallic nanoparticles using inductively coupled plasma-mass...
    Matthew Hansen, Jeffrey D. Clogston in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  6. Methods for Analysis of Nanoparticle Immunosuppressive Properties

    Adverse drug effects on immune system function represent a significant concern in the pharmaceutical industry, because 10–20% of drug withdrawal from...
    Edward Cedrone, Timothy M. Potter, ... Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  7. Ion Quantitation in Liposomal Products Using RP-HPLC with Charged Aerosol Detection

    Ion concentration in liposomal drugs is important for drug stability and drug release profile. However, quantifying ion concentration in liposomal...
    Protocol 2024
  8. Applications of Molecular Dynamics Simulations in Drug Discovery

    In the current drug development process, molecular dynamics (MD) simulations have proven to be very useful. This chapter provides an overview of the...
    Sara AlRawashdeh, Khaled H. Barakat in Computational Drug Discovery and Design
    Protocol 2024
  9. Accelerating the Discovery and Design of Antimicrobial Peptides with Artificial Intelligence

    Peptides modulate many processes of human physiology targeting ion channels, protein receptors, or enzymes. They represent valuable starting points...
    Mariana d. C. Aguilera-Puga, Natalia L. Cancelarich, ... Fabien Plisson in Computational Drug Discovery and Design
    Protocol 2024
  10. Detection of Induction of Mitochondrial Oxidative Stress by Nanoparticles in T Cells Using MitoSOX Red Dye

    The induction of oxidative stress by engineered nanomaterials has been associated with cytotoxic and inflammatory responses, damaging healthy cells...
    Ankit Shah, Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  11. Evaluation of the Acute Anaphylactoid Reactogenicity of Nanoparticle-Containing Medicines and Vaccines Using the Porcine CARPA Model

    A small fraction, up to 10%, of people treated intravenously with state-of-the-art nanoparticulate drugs or diagnostic agents develop an acute...
    Protocol 2024
  12. Detection of Intracellular Complement Activation by Nanoparticles in Human T Lymphocytes

    The complement system is complex and includes two main components: the systemic or plasma complement and the so-called intracellular complement or...
    Anna Ilinskaya, Ankit Shah, ... Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  13. AI-Driven Enhancements in Drug Screening and Optimization

    The greatest challenge in drug discovery remains the high rate of attrition across the different phases of the process, which cost the industry...
    Adam Serghini, Stephanie Portelli, David B. Ascher in Computational Drug Discovery and Design
    Protocol 2024
  14. Techniques for Develo** Reliable Machine Learning Classifiers Applied to Understanding and Predicting Protein:Protein Interaction Hot Spots

    With machine learning now transforming the sciences, successful prediction of biological structure or activity is mainly limited by the extent and...
    Jiaxing Chen, Leslie A. Kuhn, Sebastian Raschka in Computational Drug Discovery and Design
    Protocol 2024
  15. Detection of Antigen Presentation by Murine Bone Marrow–Derived Dendritic Cells After Treatment with Nanoparticles

    Nanoparticles are frequently considered in vaccine applications due to their ability to co-deliver multiple antigens and adjuvants to...
    En** Hong, Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  16. Detection of Pre-Existing Antibodies to Polyethylene Glycol and PEGylated Liposomes in Human Serum

    Polyethylene glycol, or PEG, is common in consumer products, over-the-counter medications, food, and pharmaceutical products. Concerns about PEG...
    Barry W. Neun, Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  17. Recent Deep Learning Applications to Structure-Based Drug Design

    Identification and optimization of small molecules that bind to and modulate protein function is a crucial step in the early stages of drug...
    Jacob Verburgt, Anika Jain, Daisuke Kihara in Computational Drug Discovery and Design
    Protocol 2024
  18. Protein–Ligand Blind Docking Using CB-Dock2

    Protein–ligand blind docking is a widely used method for studying the binding sites and poses of ligands and receptors in pharmaceutical and...
    Protocol 2024
  19. Detection of Beta-Glucan Contamination in Nanoparticle Formulations

    Beta-glucans with diverse chemical structures are produced by a variety of microorganisms and are commonly found in microbial cell walls....
    Barry W. Neun, Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  20. Expanding the Landscape of Amyloid Sequences with CARs-DB: A Database of Polar Amyloidogenic Peptides from Disordered Proteins

    Several databases collecting amyloidogenic regions have been released to provide information on protein sequences able to form amyloid fibrils....
    Carlos Pintado-Grima, Oriol Bárcenas, Salvador Ventura in Computational Drug Discovery and Design
    Protocol 2024
Did you find what you were looking for? Share feedback.